Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (1) , 12-22
- https://doi.org/10.1016/j.clinthera.2005.01.007
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The GlycylcyclinesDrugs, 2004
- Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1Antimicrobial Agents and Chemotherapy, 2003
- AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilisAntimicrobial Agents and Chemotherapy, 2003
- New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitorsDrug Resistance Updates, 2002
- Glycylcyclines: third-generation tetracycline antibioticsPublished by Elsevier ,2001
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- Preclinical Pharmacology of GAR-936, a Novel Glycylcycline Antibacterial AgentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Mutations in the Interdomain Loop Region of thetetA(A) Tetracycline Resistance Gene Increase Efflux of Minocycline and GlycylcyclinesMicrobial Drug Resistance, 2000
- Staphylococcus aureusInfectionsNew England Journal of Medicine, 1998
- Glycylcyclines: a new generation of tetracyclinesJournal of Antimicrobial Chemotherapy, 1995